申请人:AVENTIS PHARMA LTD
公开号:WO2003000688A1
公开(公告)日:2003-01-03
The invention is directed to physiologically active compounds of general formula (I): and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
该发明涉及具有通式(I)的生理活性化合物及含有这种化合物的组合物,以及这种化合物和它们的前药,以及这种化合物和它们的前药的药学上可接受的盐和溶剂化合物,以及在公式(I)范围内的新化合物。这些化合物和组合物具有有价值的药物特性,特别是抑制激酶的能力。